Panacea Biotec launches diabetes drug in India

Generics |  News | 0 Comment | 11 Dec, 2019

Panacea Biotec is pleased to announce launch of brand ViLACT in India. ViLACT is used in the treatment of Uncontrolled T...Read more

HEC Pharm, Biocon, Sun Pharma get FDA approval for MS drug

Generics |  News | 2 Comment | 06 Dec, 2019

The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsule...Read more

Eris Lifesciences acquires trademark Zomelis from Novartis for India market

Generics |  News | 0 Comment | 04 Dec, 2019

Eris Lifesciences has announced the acquisition of the trademark Zomelis (for Vildagliptin based formulations)...Read more

EMA and FDA accept marketing applications for Chugai's Satralizumab

Generics |  News | 0 Comment | 31 Oct, 2019

Chugai Pharmaceutical has announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Ap...Read more

Dr. Reddy’s confirms recall of all Ranitidine products

Generics |  News | 0 Comment | 24 Oct, 2019

Dr. Reddy’s Laboratories along with its subsidiaries, together referred to as “Dr. Reddy’s confirms it...Read more

Eisai, Nichi-Iko explore generic pharma biz in China

Generics |  News | 0 Comment | 01 Oct, 2019

Japan headquartered Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have announced that they have entered into a comprehens...Read more

Glenmark receives approval from Russia to market Montlezir

Generics |  News | 0 Comment | 30 Sep, 2019

Glenmark Pharmaceuticals has announced the approval from the Ministry of Healthcare, Russia to market Montlezir (Levocet...Read more

Glenmark receives Orphan Drug Designation for GBR 1342

Generics |  News | 0 Comment | 17 Sep, 2019

Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody can...Read more

Lupin launches antidepressant drug

Generics |  News | 0 Comment | 23 Aug, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 10 mg and 20 mg, having received an a...Read more

Teva launches Epinephrine Injection in the US

Generics |  News | 0 Comment | 21 Aug, 2019

Teva Pharmaceutical Industries has announced the availability of the FDA-approved generic version of EpiPen Jr®1&nbs...Read more

Sandoz launches oncology generic gefitinib in 13 EU countries

Generics |  News | 0 Comment | 10 Jul, 2019

Sandoz has announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally adv...Read more

Teva announces launch of a generic version of Tracleer® in US

Generics |  News | 0 Comment | 20 Jun, 2019

Teva Pharmaceutical Industries Ltd. has announced the launch of a generic version of Tracleer® (bosentan) tablets, 6...Read more

Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2)

Generics |  News | 0 Comment | 05 Jun, 2019

Pharma major Lupin has announced the completion of the Good Manufacturing Practices (GMP) inspection of its Mandideep fa...Read more

GSK announces approval of Shingrix in China

Generics |  News | 0 Comment | 27 May, 2019

GlaxoSmithKline has announced that the National Medical Products Administration (NMPA) has approved Shingrix for the pre...Read more

FDA approves SORILUX(R) for Adolescent Plaque Psoriasis

Generics |  News | 0 Comment | 23 May, 2019

Mayne Pharma Group Limited has announced that the US Food and Drug Administration (FDA) has approved SORILUX® (...Read more

Sandoz receives regulatory approval from NMPA for Rosuvastatin

Generics |  News | 0 Comment | 09 May, 2019

Sandoz has announced that it has received regulatory approval from China's National Medical Products Administration (NMP...Read more

Alembic set to sell its drugs into Chinese market

Generics |  News | 0 Comment | 08 May, 2019

Alembic has entered into a Joint Venture Agreement ('JVA') with SPH SINE Pharmaceutical Laboratories Co Ltd, China ('SPH...Read more

CStone, Numab enter into an exclusive licensing agreement for ND021

Generics |  News | 0 Comment | 02 May, 2019

CStone Pharmaceuticals and Numab Therapeutics AG have entered into an exclusive regional licensing agreement for the dev...Read more